TrialBMJ open2021

Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.

Guillaume Voiriot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.